Medicines for children

An intergal practice of the European Commission's pharmaceutical unit is to ensure a good quality of medicinal products for paedriatic use. In response to the incidence of inadequate medicines for children in Europe, the European Commission implemented a proposal on the 29th September 2004. Additionally this legislation seeks to promote the development of paediatric medicines, whereby at the national scale of EU member states have a role to play in providing national incentives for the research and development of such pharmaceuticals.